Table 1.
Author/year | Sex/age | Lesion | Pathology | FNA | Anticoagulant or antiplatelet therapy | Time of bleeding | Bleeding lesion | Outcome |
---|---|---|---|---|---|---|---|---|
Roseira et al., 2019 [3] | Male/65 | A pancreatic head mass in the setting of idiopathic chronic pancreatitis | Not mentioned | 22G needle, 3 passes from duodenal bulb | No | 3 weeks after EUS-FNA | Intramural duodenal hematoma | Conservative therapy. Improvement within 15 days |
Sendino et al., 2010 [4] | Not mentioned | Cystic pancreatic lesion | Not mentioned | 19G needle, with EchoBrush | Anticoagulation therapy stopped 2 days before EUS-FNA | 1 week after EUS-FNA | Retroperitoneal hemorrhage | Died |
Tomoya et al., 2015 [2] | Male/64 | A pancreatic body mass | Invasive pancreatic ductal cancer | 22G needle, 2 passes, 10 strokes each | Edoxaban started after EUS-FNA to treat inferior vena cava thrombi | 10 days after EUS-FNA | An ulcer at the puncture site on a background of atrophied gastric mucosa | Coagulation hemostasis performed with coagulation forceps, recovery |
Our case | Male/33 | Diffusely enlarged pancreas | Type I autoimmune pancreatitis | 19G needle, 1 pass, 10 strokes | No | 6 days after EUS-FNA | Mucosal swelling at the puncture site with bleeding | Titanium clips, recovery |
FNA: Fine needle aspiration